Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective Evaluation of Suzetrigine in Spine Surgery
NCT07829718Phase 4Not yet recruiting
- Sponsor
- The Ohio State University
- Start
- Sep 2026
- Primary completion
- Dec 2030
01
Overview
Phase 4, open-label, single-arm trial of suzetrigine in postoperative pain, sponsored by The Ohio State University. Primary endpoint: Total Opioid Consumption During the First 48 Hours After Surgery. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
suzetrigine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07829718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07829718.